Pre-formulation
Key Takeaways
Develops pre-formulation strategies for pharmaceutical compounds
Original Description
In this course we will focus on how active compounds are developed into a formulation suitable for dosing in animal studies and early human clinical trials. Factors such as the route of administration, enhancing the solubility of the drug substance, the crystalline form of the drug substance, drug substance vs. drug product, storage requirements, and how special requirements of the patient population play a role in the design of an ideal formulation will be covered. Finally, some of the differences encountered when formulating a biologic vs. a small molecule will be discussed.
Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.
AI explanation not available for this lesson yet
This lesson is still being prepared for the AI tutor. In the meantime, explore lessons that are ready.
Browse explainer-ready lessons →
Related Reads
📰
📰
📰
📰
Search Broadly, Seek Evidence on Both Sides, Decide Narrowly: Evidence-Admissible GraphRAG for Longitudinal Clinical Event Verification
ArXiv cs.AI
From Hard-Coded Retrieval to Real Semantic Search in an Enterprise Multi-Agent AI Platform
Medium · RAG
From 7K to 72K QPS: Scaling Vector Search for RAG and AI Workloads with NVMe-oE
Medium · RAG
Choosing the Right OCR in 2026
Medium · RAG
🎓
Tutor Explanation
DeepCamp AI